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Abstract: The hospital environment significantly contributes to the onset of healthcare associated
infections (HAIs), representing the most frequent and severe complications related to health care.
The monitoring of hospital surfaces is generally addressed by microbial cultural isolation, with some
performance limitations. Hence there is need to implement environmental surveillance systems
using more effective methods. This study aimed to evaluate next-generation sequencing (NGS)
technologies for hospital environment microbiome characterization, in comparison with conventional
and molecular methods, in an Italian pediatric hospital. Environmental samples included critical
surfaces of randomized rooms, surgical rooms, intensive care units and delivery rooms. The resistome
of the contaminating population was also evaluated. NGS, compared to other methods, detected
with higher sensitivity the environmental bacteria, and was the only method able to detect even
unsearched bacteria. By contrast, however, it did not detect mycetes, nor it could distinguish viable
from dead bacteria. Microbiological and PCR methods could identify and quantify mycetes, in
addition to bacteria, and PCR could define the population resistome. These data suggest that NGS
could be an effective method for hospital environment monitoring, especially if flanked by PCR for
species identification and resistome characterization, providing a potential tool for the control of
HAI transmission.
Keywords: healthcare-associated infections; antimicrobial resistance; contamination; molecular
methods; next generation sequencing
1. Introduction
Healthcare-associated infections (HAIs) represent one of the most frequent and severe
complications of hospitalization worldwide, as 5%–15% of all hospitalized inpatients acquire them
during hospitalization [1]. In Europe, more than 4 million of patients develop HAIs each year [2,3],
and in Italy the incidence of infectious complications generally varies from 5%–10%, with a mortality
rate of 20%–30% [4]. HAIs are known to be responsible for significant excess morbidity and mortality,
lengthening the duration of stays, as well as imposing additional costs on health systems [5]. They are
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frequent in several ward types, including pediatric wards, as children are particularly susceptible to
infections due to several factors, including an immature immune system, the presence of acquired or
congenital immunodeficiencies, effects caused by anti-cancer therapy, etc. [6].
In addition, antimicrobial resistance (AMR) is currently spreading worldwide, representing one
of the major threats for human health, and is particularly dangerous in healthcare settings, where
antimicrobials are heavily used, exerting an important selective pressure on microbes. Not surprisingly,
AMR is strongly associated with HAI severity, as many HAIs are caused by multidrug resistant (MDR)
or even pan-drug resistant (PDR) microbes [7,8].
Persistent contamination of hospital surfaces by potential pathogens significantly contributes
to HAI onset, being an environmental reservoir for several microbes, including methicillin-resistant
Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile, Pseudomonas
aeruginosa, Acinetobacter spp., as well as viruses [9–12]. It is generally accepted that hospital
contamination is associated with HAI transmission [13,14], as the risk of acquiring an infection
caused by a specific microbe increases for a person admitted in a hospital room that was previously
occupied by a patient colonized or infected by the same infectious agent [15]. This is due to the
ability of resilient microorganisms to survive for long period on surfaces [16], from where they can be
easily transmitted to other patients [14], or shed in other rooms to unaffected patients by horizontal
transmission from asymptomatic carriers, such as healthcare workers or visitors [17].
Therefore, it is clear that environmental cleaning in hospitals has a crucial role in reducing
microbial contamination of surfaces and the subsequent risk for HAIs. Scientific evidence reports
that an adequate and correct cleanliness, accompanied by specific campaigns to raise awareness for
importance of hand hygiene, is associated with a reduction of surface contamination and a concomitant
decrease of pathogen transmission to patients [12,18].
In this regard, we recently showed that abating microbial contamination and its AMR in the
hospital environment, using a cleaning procedure, was associated with a significant reduction of
HAI incidence [19] suggesting that it could be used as a potential strategy for infection control
and prevention.
Defining the hygiene of the healthcare setting environment is not simple. A solely visual
assessment provides only a rough indication of “cleanliness”, and cannot predict the real infection risk
for patients [10,20]. From this perspective, specific methods able to assess the microbial presence in
the hospital environment represent an important point for the control of pathogenic contamination
and infection prevention. Until now, monitoring of hospital environmental surfaces took place by
microbiological, culture-based methods [21,22], which however show important limitations mostly
linked to the need for culture isolation and culture time [22]. Indeed, although being able to detect
viable bacteria or fungi, these methods can detect only known microbes, by using specific selective
media, need long incubation times and specific conditions (temperature and atmosphere) to allow
microorganisms to grow, rendering them very time-consuming and complex when used for the analysis
of a whole microbial population [22].
By contrast, an efficient environmental monitoring system should be precise and rapid, able to
provide a detailed characterization of the bioburden as soon as possible. In this regard, the assessment
of the effectiveness of cleaning procedures performed by measurement of adenosine triphosphate
(ATP) by bioluminescence, is a rapid method, but has low accuracy since it can also detect organic
materials, providing potential false positive results [23]. Furthermore, it cannot distinguish between
pathogenic and non-pathogenic microorganisms. Hence the urgency for implementing environmental
surveillance systems to characterize environmental bioburden.
Molecular methods based on DNA technologies might overcome such limitations, providing
accurate information in real time and helping to characterize in detail the whole microbial population
colonizing hospital surfaces. To address this aim, specific PCRs and real-time PCRs have been set up
and developed [19,22,24,25]. However, the advent of modern technologies based on DNA sequencing
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has considerably improved microbiome investigation allowing definition of complex populations in
deep detail [26], and could also be employed for environmental surveillance [22].
Lastly, several studies have been performed to characterize the microbial contamination in the
hospital wards hosting adult patients, but considerably less is known about the contamination level
and type in paediatric healthcare settings.
Based on these considerations, the present study aimed to characterize the contamination in an
Italian paediatric hospital, by using next generation sequencing (NGS) technologies in comparison
with conventional microbiological and molecular PCR methods, trying to define surface microbiomes
and to characterize advantages and disadvantages of the compared technologies.
2. Materials and Methods
2.1. Environmental Sampling
The study was conducted after obtaining approval from the Institutional Scientific Board of
the Institute for Maternal and Child Health “IRCCS Burlo Garofolo” (Trieste, Italy) in the following
wards: Pediatric Clinic (PC), Pediatric Surgery (PS), Pediatric Oncology (PO), Neonatal Intensive and
Sub-Intensive Care Unit (NICU and NICUs), children’s Intensive Care Unit (ICU), Surgical Rooms (SR:
Orthopedics, Gynecology and Oculistics) and Delivery Room (DR).
Two sampling campaigns were performed for each enrolled ward, in which up to three rooms/wards
were monitored. Environmental samples were collected seven hours after cleaning, a time chosen
based on our previous studies on hospital contamination, showing that this time point is representative
of the contamination level in a 24-h period [19,25,27]. Different hard surfaces were sampled based on
the characteristics of the individual wards: floor for all ward types; bed footboard, operating bed or
incubator for inpatients wards, ICU, SR and NICU, respectively; sink or operating table for inpatients
rooms or SR/DR, respectively. The same points were simultaneously sampled following two different
methodologies according to subsequent microbiological or molecular analyses.
2.2. Microbiological Analyses
For microbiological analyses, sampling was performed in duplicate by using Replicate Organism
Detection and Counting (RODAC) contact plates containing the following specific culture media: total
bacteria (TSA medium, Merck Millipore, Milan, Italy), Staphylococcus spp. (Baird Parker medium,
Merck Millipore, Milan, Italy), Enterobacteriaceae spp. (MacConkey medium, Merck Millipore, Milan,
Italy), Acinetobacter spp. (Herella medium, Lickson, Milan, Italy), Pseudomonas spp. (Cetrimide medium,
Incofar, Modena, Italy), Clostridium difficile (Clostridium difficile selective medium, Lickson, Milan, Italy),
Enterococcus spp. (BEA medium, Incofar, Modena, Italy) and mycetes (Sabouraud medium, Merck
Millipore, Milan, Italy). Plates for general or selective growth of bacteria were incubated at 30 ◦C
for 24–48 h (respectively for general and selective media), whereas plates for the specific growth of
mycetes were incubated at 25 ◦C for 72 h. Colony forming units (CFU) were then enumerated. Plates
containing ≥ 200 CFUs were considered to have 200 CFUs, following the guideline INAIL-2017 [28]. A
total of 216 samples were collected from surfaces.
2.3. Molecular Analyses
For molecular analyses, 108 total environmental samples representing total microbial population
were collected by sterile rayon swabs rubbed on a 10 × 10 cm area as previously described [25]. Swabs
were pre-moistened in sterile Tryptic Soy Broth (TSB) or saline, depending on the subsequent analysis
type, and rubbed swabs were put in 5 mL TSB or 0.4 mL saline respectively, immediately refrigerated
and transported to the laboratory.
Samples collected in TSB were incubated at 37 ◦C for 24 h for a controlled bacterial amplification;
afterwards microbial cells were pelletized (14,000 × g for 5 min) and stored until use at −20 ◦C as
already described [19]. Microbial DNA was extracted from microbial pellets by the QIAmp UCP
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Pathogen Mini Kit (Qiagen, Hilden, Germany), and analyzed by the Microbial DNA qPCR Array
for Antibiotic Resistance Genes (Antibiotic Resistance Genes, catalog no. BAID-1901ZRA; Qiagen),
allowing the detection and quantitation of 84 genes coding for antimicrobial resistance, as previously
described [25,27]. An amount of 1 µg of extracted DNA per plate (10 ng/well/reaction) was used for R
gene microarray analysis.
Samples collected in saline were immediately frozen at −80 ◦C, without amplification, and
used to quantify microbial communities in sampling real time. After being thawed and vortexed,
total DNA was extracted from 300 µL of each sample by the Exgene Cell SV Kit (Gene All, Tema
Ricerca, Bologna, Italy), in a final elution volume of 100 µL. DNA samples were then analyzed by a
customized qPCR microarray (BAID-00047RA Qiagen, Hilden, Germany), assessing simultaneously
the presence of the following microbes: S. aureus, S. epidermidis, E. faecalis, E. faecium, E. coli, K.
pneumonia/Enterobacter, A. baumannii, P. mirabilis, P. aeruginosa, C. perfringens, C. difficile, A, fumigatus and
C. albicans, as previously reported [29]. An amount of 120 ng per sample (corresponding to 7 ng of
template DNA per well/reaction) was used for the custom-array analysis.
2.4. NGS Analyses
For NGS analyses, environmental samples were collected as described for qPCR molecular assays,
then total DNA was extracted in a final elution volume of 50 µL by the automatic extractor Maxwell
CSC DNA Blood Kit (Promega, Madison, WI, USA), according to manufacturer’s instruction. DNA
samples were stored at −80 ◦C prior to further processing.
The characterization of the bacterial composition of the samples was performed by sequencing the
region V3 of the 16S rRNA gene. First, a qPCR targeting the V1–V3 region 16S rRNA gene (500 bp), was
performed using EvaGreen® dye (Fisher Molecular Biology, Waltham, MA, USA), by employing the
U534R primer (U534R 5′-ATTACCGCGGCTGCTGG-3′) and the degenerated primer 27FYM (5′-AGR
GTT YGA TYM TGG CTC AG - 3′). A nested PCR was subsequently carried out with the primers
B338F_P1-adaptor (B338F 5′-ACTCCTACGGGAGGCAGC-3′) and U534R_A_barcode, targeting the V3
region (200 bp) of the 16S rRNA gene, with a different barcode for each sample linked to the reverse
primer [30]. The analysis was simultaneously performed on negative controls, including no DNA
template. The PCR reactions were performed using the Kapa 2G HiFi Hotstart ready mix 2X (Kapa
Biosystems, Wilmington, MA, USA) and BSA 400 ng/µL, under the following temperature cycling
conditions: 95 ◦C for 5 min, 95 ◦C for 30 sec, 59 ◦C (V1–V3 PCR)/57 ◦C (V3 PCR) for 30 sec, and 72 ◦C
for 45 sec with a maximum of 27 cycles for the V1–V3 PCR and a maximum of 13 cycles for the V3 PCR.
Final elongation step was of 10 min at 72◦C.
After assessing the correct size of the amplicon (260 bp) on a 2% acrylamide gel, the DNA
quantification was performed by a Qubit® 2.0 Fluorimeter (Invitrogen, Carlsbad, CA, USA) and an
equal amount of each sample was mixed to generate a pooled library at a final 100 pM concentration,
according to manufacturer’s instructions. The Ion OneTouch™ 2 System (Life Technologies, Gran Island,
New York, NY, USA) was used to prepare the template with the Ion PGM Hi-Q View OT2 200 kit (Life
Technologies, New York, NY, USA). Sequencing was performed with the Ion PGM™ System technology
by using the Ion PGM Hi-Q View sequencing kit (Life Technologies, New York, NY, USA). Quantitative
Insights Into Microbial Ecology (QIIME 1.9.1.) software, allowing analysis of high-throughput
community sequencing data [31] (available at: https://www.nature.com/articles/nmeth.f.303; accessed:
1st October 2019) was used to process the sequence data. High quality sequences (Q > 25) were
demultiplexed and filtered by quality using split_libraries_fastq.py with default parameters, except
for the length (150 bp). Sequences with homopolymer length >8 or ambiguous bases were removed.
Operational Taxonomic Units (OTUs) were clustered with a similarity threshold of 97% and aligned
against the reference taxonomy database SILVA V.132 [32].
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2.5. Statistical Analyses
Statistical analyses were performed using parametric Student’s t-test and assuming as statistically
significant a P value at least <0.05. Bonferroni correction for multiple comparisons was applied for
analysis of microarray data (a Pc value <0.05 was considered significant). NGS data were statistically
analyzed by QIIME 1.9.1. Beta diversity, assessed by weighted and unweighted UniFrac distance
matrices [33], and presented with principal coordinates analysis (PCoA). Analyses of Similarities
(ANOSIM) was performed to compare the composition of microbial community among the tested
ward surfaces.
3. Results
3.1. Environmental Analyses by Conventional Microbiology
In order to characterize the environmental microbial contamination in a pediatric Italian hospital,
different wards were sampled and analyzed in parallel by conventional microbiological as well by
molecular methods. Areas included: Pediatric Clinic (PC), Pediatric Surgery (PS), Pediatric Oncology
(PO), Neonatal Intensive and sub-Intensive Care Unit (NICU and sNICU), children’s Intensive Care
Unit (ICU), Surgical Rooms (SR: Orthopedics, Gynecology and Oculistics) and Delivery Room (DR)
were included in the analyses. Each ward was sampled in two consecutive sampling campaigns, and
up to three rooms per ward were tested. The following critical surfaces were sampled, as they are
particularly representative of hospital contamination based on previous results [19,27]: floor, bed
footboard and sink for inpatients wards and ICU; floor, operating bed and operating table for SR
and DR; floor, incubator and sink for NICU. Each sample was collected in duplicate by applying
Replicate Organism Detection and Counting (RODAC) contact plates directly to the sampled point.
RODAC contained different general and selective media allowing detection and quantification of
the following HAI-related microorganisms: total bacteria (TSA medium), Staphylococcus spp. (Baird
Parker selective medium), Enterobacteriaceae spp. (MacConkey selective medium), Acinetobacter spp.
(Herella selective medium), Mycetes (Sabouraud selective medium), Pseudomonas spp. (Cetrimide
selective medium), Clostridium difficile (Clostridium difficile selective medium), and Enterococcus spp.
(BEA selective medium). Plates were incubated as described in the Materials and Methods section
based on the type of microorganism, and colony forming units (CFU) were enumerated. A total of 216
microbiological samples (108 surfaces in duplicate) were collected and analyzed.
Results showed a diverse level of contamination in the different wards, as expected (Figure 1A).
Most of contamination was ascribable to potential pathogens (Figure 1B), largely represented by
Staphylococcus spp. (Figure 1C). In particular, PC was the ward with the highest level of contamination,
having a median total CFU count corresponding to 40,842 CFU per square meter (95% CI 30,412–54,664).
A considerable proportion of contaminants were represented by the searched pathogens (including
Staphylococcus spp., Enterobacteriaceae, Klebsiella spp., Acinetobacter spp., Pseudomonas spp., Clostridium
difficile, Enterococcus spp., Candida spp., Aspergillus spp.), whose sum resulted in a median value of
12,000 CFU/m2 (95% CI 2526–40,545), representing 69.5% of the total mean microbial contamination.
Pathogen contamination was highly referable to Staphylococcus spp. (median CFU 12,985/m2, 95% CI
2526–39,662). PS had a similar value of contamination, with a total median value of 29,474 CFU/m2
(95% CI 25,762–47,619), and with a median value of pathogens corresponding to 15,579 CFU/m2 (95% CI
2631–31,580), highly represented by Staphylococcus spp. (median 12,000 CFU/m2, 95% CI 2105–30,188).
Rooms of sNICU ward had levels of contamination similar to PS, with a median value of
total contaminants corresponding to 23,158 CFU/m2 (95% CI 19,387–38,485), the sum of pathogens
corresponding to a median value of 23,158 CFU/m2 (95% CI 1579–42,515), and the Staphylococcal
median contamination at 17,474 CFU/m2 (95% CI 1263–27,673). The PO ward showed a median
total count of 13,894 CFU/m2 (95% CI 11,948–26,392), with a median pathogen level corresponding
to 4210 CFU/m2 (95% CI 28,56–13,354), mostly referable to Staphylococcus genus (median value 4210
CFU/m2; 95% CI 526–13,224). Compared to the other wards, ICU and NICU showed a considerably
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lower degree of contamination, having respectively a median total value of 9474 CFU/m2 (95% CI
5234–45,082) and 9895 CFU/m2 (95% CI 6.346–48,882). The median value of the sum of the ten searched
pathogens corresponded to 7158 CFU/m2 in ICU (95%CI 1053–17,723), and to 7579 CFU/m2 in NICU
(95% CI 105–57,343). In both wards, staphylococci represented the majority of pathogenic contaminants,
corresponding respectively to 6947 CFU/m2 in ICU (median value; 95% CI 1053–16,871), and 7579
CFU/m2 (median value; 95% CI 105–26,435) in the NICU ward. As expected, SR and DR showed a
very low level of total microbial contamination, corresponding respectively to a median value of 1263
CFU/m2 (95% CI 1459–5348) and 842 CFU/m2 (95% CI 0–8793). The sum of pathogens corresponded
respectively to a median value of 0 CFU/m2 in SR (95% CI 0–1842), and 210 CFU/m2 in DR (95% CI
0–2889), with a median amount of staphylococci corresponding to 0 CFU/m2 in SR (median value; 95%
CI 0–1821), and 210 CFU/m2 in DR (median value; 95% CI 0–2889).
Figure 1. Microbial contamination in wards analyzed by conventional culture-based methods. (A) Total
contamination, corresponding to CFUs obtained on TSA medium; (B) pathogen contamination,
corresponding to the sum of the searched pathogens (CFUs obtained on selective media);
(C) staphylococcal contamination, corresponding to CFUs obtained on selective BP medium. All results
are expressed as median value of CFU/m2 with interquartile range. PC, Pediatric Clinic; PS, Pediatric
Surgery; NICU, Neonatal Intensive; sNICU, sub-Intensive Care Unit; ICU, children’s Intensive Care
Unit; SR, Surgical Rooms; DR, Delivery Room; PO, Pediatric Oncology.
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No statistically significant differences emerged among PC, PS and sNICU, whereas PO, NICU
and ICU were significantly less contaminated (p < 0.01). SR and DR, as expected, were significantly
different both compared to the PC–PS–sNICU group (p < 0.0001) and to the PO–NICU–ICU group (p <
0.001).
The highest level of contamination was found on floor, and similarly high values were also
detected in sinks (Figure 2A) (p = ns). Bed footboards resulted significantly less contaminated (p <
0.01), and minimal levels of microbial contamination were detected, as expected, on the other tested
surfaces (operating beds, surgery tables and incubators) (p < 0.0001). Most microbial contamination
consisted in potential pathogens, as the sum of the ten searched pathogens represented up to 90% of
the total contamination (Figure 2B), mostly represented by Staphylococcus spp. (Figure 2C).Microorganisms 2019, 7, x FOR PEER REVIEW 8 of 22 
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Figure 2. Microbi l contami ation on analyzed surfaces by conventional culture-based methods:
(A) Total contamination, corresponding to CFUs obtained on TSA medium; (B) Pathogen contamination,
corresponding to the sum of CFUs of the searched pathogens on selective media; (C) Staphylococcal
contamination, corresponding to CFUs obtained on selective BP medium. All the results are expressed
as the median value of CFU/m2 with interquartile range.
Although the high level of contamination ascribable to the Staphylococcus genus, which was
detected in 175/216 samples (81%), the species S. aureus was identified uniquely in one out of all the
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collected samples, suggesting that the vast majority of staphylococci contaminating the tested surfaces
were coagulase-negative strains. Compared to Staphylococcus spp., the other searched microbial genera
appeared much less represented (Figure 3).
Figure 3. Main genera/species/families detected on tested surfaces by conventional culture-based
methods. Results represent the percentage of detection of the indicated genera/species/families on the
total collected samples (216 samples).
Enterococcus spp., representing the most prevalent contaminant genus after Staphylococcus, were
detected in 28 samples, exclusively from floors and sinks, mostly from PC rooms and partly from
sNICU and PO wards. Acinetobacter spp. was isolated from 16 sampled surfaces, prevalently from
floors and sinks from ICU, sNICU and PS wards. C. difficile was evidenced in 9 samples from floors and
sinks of PC and sNICU, whereas Enterobacteriaceae were generally scarcely detected, being isolated
in only 4 samples (2 sinks and 2 floors from PC and PS wards), concomitantly with Klebsiella spp. in
one of the sinks samples. Similarly, P. aeruginosa was identified uniquely in two sink samples from
PC rooms. With regard to mycetes, Candida spp. were evidenced in 17 samples from sinks of PC and
sNICU wards, whereas Aspergillus spp. were never detected.
3.2. Environmental Analyses by Molecular Assay (qPCR Microarray)
The same points sampled for microbiological analysis were in parallel collected by moistened
swabs rubbed on a 10 × 10 cm surface for molecular analysis. A total of 108 total swab samples were
collected, from which total DNA was extracted and analyzed by a quantitative real-time PCR (qPCR)
customized array, assessing simultaneously the presence of the following bacterial and mycotic species:
S. aureus, S. epidermidis, E. faecalis, E. faecium, E. coli, K. pneumonia/Enterobacter, A. baumannii, P. mirabilis,
P. aeruginosa, C. perfringens, C. difficile, A, fumigatus and C. albicans. Total bacterial and mycetes DNA was
also assessed in parallel, respectively by a pan-bacterial and pan-mycetes qPCRs included in the array
as a control. The results allowed the identification of the searched pathogens in more surface samples
compared to conventional methods (Figure 4). In fact, genus Staphylococcus was identified in 107 out
of 108 samples (99%), including 60 samples positive for the presence of S. aureus (55%). Enterococcus
genus was detected in 86 samples, of which 49 harbored E. faecalis and 37 E. faecium, respectively.
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Bacteria belonging to the Enterobacteriaceae family were evidenced in many samples, compared to
what was detected by microbiological analysis, as K. pneumonia/Enterobacter was evidenced in 84/108
collected samples, often in association with E. coli (in 53 samples), A. baumannii (in 26 samples), P.
mirabilis (in 13 samples), P. aeruginosa (in 82 samples), C, perfringens and difficile (in 37 and 20 samples,
respectively). Also searched-for mycetes were quite represented in surface microbiomes, as C. albicans
and A. fumigatus species were detected in 42 and 18/108 environmental samples, respectively.
Figure 4. Comparison of culture-based and molecular methods in the efficiency of detection of
microbial contamination in all analyzed samples. (A) Culture-based methods (216 total samples).
(B) Molecular qPCR assay (108 total samples). Results represent the percentage of detection of the
indicated families/genera/species on the total collected samples.
The highest levels of contamination were observed in the PC and PS wards, as judged
by summing up the genome copy amounts measured by qPCR, whereas SR and DR were less
contaminated, confirming what was observed by conventional microbiological analyses (Figure 5).
Statistically significant differences were observed between PC–PS wards and the group of wards
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NICU–sNICU–ICU–PO (p < 0.05). SR and DR were significantly different from both the first (p >
0.0001) and the second group of wards (p < 0.001).Microorganisms 2019, 7, x FOR PEER REVIEW 12 of 22 
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Figure 5. Quantitation of microbial contamination by qPCR molecular assays. (A) Microbial
contamination in the analyzed wards, expressed as median value of genome copy number/m2,
with interquartile range. (B) Microbial co tamination on the analyzed surfaces, expressed as median
value of genome copy number/m2, with interquartile range. PC, Pediatric Clinic; PS, Pediatric Surgery;
NICU, Neonatal Intensive; sNICU, sub-Intensive Care Unit; ICU, children’s Intensive Care Unit; SR,
Surgical Rooms; DR, Delivery Room; PO, Pediatric Oncology.
On average, the m a ur ment of g nome copy numbe yielded higher values of contamination
per square meter, compared to CFU counts. This result might be due to a higher sensitivity of
molecular compared to cultural assays, or to the measurement of total microbes (molecular methods)
versus exclusively viable microbes (cultural methods). In fact, whereas direct CFU count detects only
viable microbes, total DNA extraction and subsequent microbial genome counting does not allow
investigators to distinguish between living and dead bacteria, possibly resulting in an overestimation
of infectious contaminating microbes.
qPCR microarray analyses were also used to characterize the resistome of the contaminating
microbial population, allowing simultaneous detection and quantification of 84 different resistance (R)
genes. The results, summarized in Figure 6, revealed the presence of several genes coding antibiotic
resistance in the surface microbiome. In particular, methicillin-resistance gene (mecA), likely ascribable
to the presence of Staphylococcus spp., was detectable in most analyzed environments, except for DR,
together with other R genes conferring resistance against macrolides (ermA, ermB), and β-lactams,
including carbapenems (VIM-group,OXA group). msrA and ermC (respectively providing the resistance
against macrolides and erythromycin) were also highly represented, whereas IMP-5 group and NDM
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gene (New Delhi metallo-β-lactamase) were particularly represented only in the ICU ward. Since these
genes are associated with the resistance to carbapenems in Gram-negative bacteria, their prevalence
likely reflected the presence/selection of strains resistant to that class of antibiotics in the ICU ward.
Overall, resistome analysis results paralleled the contamination level, with wards harboring high levels
of R genes (PC, PS) and other, such SR and DR, where drug-resistance was barely or at all detectable in
the few contaminating strains.
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Comparison of the resistome detected in the contaminating population of the different wards did
not reveal any statistically significant difference among PC, PS, ICU and sNICU, although a generally
higher number of R genes at higher levels were observed in PC and PS wards compared to ICU and
sNICU. By contrast PO, ICU and NICU grouped together as no statistically significant differences
were detected among them, but they showed significantly lower resistance (p < 0.05) compared to
PC, PS, ICU and sNICU. Lastly, SR and DR did not differ significantly from each other, but harbored
a lower number and level of R genes both compared to PO-ICU-NICU group (p < 0.001) and to the
PC-PS-ICU-sNICU group (p < 0.0001).
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3.3. Environmental Analyses by NGS
The microbial communities of the same environmental locations were analyzed in parallel by
NGS. Overall, the most frequently detected bacterial genera were Cutibacterium spp. (formerly
Propionibacterium), detected in 102/108 of the total analyzed samples, Staphylococcus spp. (100/108
samples), Streptococcus spp. (89/108 samples), Corynebacterium spp. (81/108 samples), Pseudomonas
spp. (81/108 samples), Paracoccus spp. (76/108 samples), Acinetobacter spp. (71/108 samples), and
Rothia spp. (64/108 samples). By grouping the samples according to the type of surface (Figure 7),
the bacteria showing the highest percentages of relative abundance, compared to the other detected
genera, were Cutibacterium spp., representing the major contaminant of operating tables (mean relative
abundance 23%) and operating beds (mean relative abundance 19%), where it was present on all
tested surfaces (8/8 operating beds and 8/8 operating tables). The other bacteria detected at high
relative abundance on the operating tables included Delftia spp. (mean relative abundance 12%, in
6/8 operating tables), Staphylococcus spp. (mean relative abundance 5%, in 7/8 samples), Streptococcus
spp., and Nitrareductor spp. (4% in 2/8 tables and 6% in 5/8 tables, respectively). In operating beds,
with abundance percentages ranging from 1% to 7%, Pseudomonas spp. (7/8 samples), Delftia spp. and
Nitrareductor spp. (6/8 samples), Corynebacterium spp. and Staphylococcus spp. (5/8 samples), and
Streptococcus spp. (4/8 samples) were frequently observed.
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Staphylococcus spp. represented the main contaminant of the floors (mean relative abundance 8%),
where it was present in all the analyzed samples (36/36). In addition, on floors Corynebacterium spp.
(32/36), Cutibacterium spp. (35/36) and Streptococcus spp. (32/36) were also frequently identified, with
relative abundance percentages ranging from 1% to 5%. In sinks, Streptococcus spp. was present with
the higher value of relative abundance (9%, in 27/28 sinks), together with Staphylococcus spp. (7%, in
27/28 samples). Cutibacterium spp. (24/28 samples) and Pseudomonas spp. (22/28 samples) were also
frequently detected in this type of surface. In the incubators the main contaminants were Pseudomonas
spp., Staphylococcus spp., Cutibacterium spp., and Streptococcus spp.; these last two microorganisms
were found in all the incubators analyzed (8/8 samples). The means of relative abundance values were
between 4% and 8%. Streptococcus spp. was also the bacterium showing the highest values among the
bed footboards (mean relative abundance 7%).
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By grouping the samples on the basis of the analyzed ward (Figure 8), regardless of the type
of surface analyzed, we noticed that the bacterial genera found with the highest relative abundance
percentages were Cutibacterium spp. (18% in SR with 18/18 samples, and 11% in DR with 6/6 samples)
and Staphylococcus spp. (18% in NICU, in 6/6 samples). In NICU, with percentages of relative abundance
from 1% to 5%, Rothia spp., Cutibacterium spp., Streptococcus spp., and Escherichia–Shigella spp. were
also identified in all the surfaces considered (6/6 samples).
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Of ote, in SR, Staphylococcus s p. and Pseudomonas spp. were both observed in 16/18 samples,
with mea i e abundances respectively of 8% and 3%, and Delftia spp. was detected in 13/18
samples at ndance. Analyzing the bacterial c mposition of the samples from S d PC and
sNICU, Staphylococcus spp. and Streptococcus spp. were the bacteria ith the highest values of relative
abundance (6%, 11% and 18% respectively), and in particular in sNICU were detected on 16/18 and
17/18 of surfaces analyzed. Among other bacteria frequently found in sNICU, Acinetobacter spp.,
Pseudomonas spp., Cutibacterium spp. and Corynebacterium spp. were detected. In ICU, the main
bacterial contaminants were represented by Acinetobacter spp., Cutibacterium spp. and Pseudomonas
spp., which were detectable in all the tested ward surfaces, with relative abundance values between 2%
and 4%. In PO, again, the main contaminant was Cutibacterium spp. (mean relative abundance 8%),
followed by Staphylococcus spp. and Paracoccus spp. (both 5% of relative abundanc ). As shown in
Figures 7 and 8, m ny other ba terial genera were identified, with relative abundance percentages
ranging from 1% to 3%, some of which could be potential pathogens.
The overall microbial diversity comparison between samples (β-diversity) was performed using
the unweighted and weighted UniFrac distance matrices. The results were visualized by a Principal
Coordinates Analysis (PCoA), both with weighted and unweighted UniFrac. According to the grouping,
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a one-way Analysis of Similarity (ANOSIM) statistical test was applied to the UniFrac distance matrices
to test for significant differences. Regarding the comparison between samples grouped by type of
surface considered, ANOSIM attributed a significant difference to the grouping both for the weighted
(Figure 9a) (p = 0.01, R = 0.21), and the unweighted UniFrac (Figure 9b) (p = 0.01, R = −0.47). Also
as regards the grouping of the samples by ward, ANOSIM attributed a significant difference both
for the weighted (Figure 10a) (p = 0.01, R = 0.13) and unweighted (Figure 10b) (p = 0.01, R = 0.14)
UniFrac. These tests show there are significant statistical differences between the surfaces, in particular
clustering is noted with in the floors and the operating tables.
Figure 9. Results of UniFrac-based Principal Coordinates Analysis (PCoA) on tested surfaces. Emperor
PCoA plot generated from the jackknifed_beta_diversity.py script of QIIME showing the clustering
of bacterial communities according to the type of surface analyzed. Weighted (a) and unweighted,
(b) UniFrac-based PCoA; each dot represents a sample.
Figure 10. Results of UniFrac-based Principal Coordinates Analysis (PCoA) in analyzed wards.
Emperor PCoA plot generated from the jackknifed_beta_diversity.py script of QIIME showing the
clustering of bacterial communities according to the wards considered. Weighted (a) and unweighted
(b) UniFrac-based PCoA; each dot represents a sample. PC, Pediatric Clinic; PS, Pediatric Surgery;
NICU, Neonatal Intensive; sNICU, sub-Intensive Care Unit; ICU, children’s Intensive Care Unit; SR,
Surgical Rooms; DR, Delivery Room; PO, Pediatric Oncology.
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4. Discussion
Recent studies show how built environments can be considered as super-organisms, with their
own microbiome, highly affected by the presence of human beings [34]. For hospital environments,
the kind of persisting microbiome is particularly important as it is directly correlated with the risk of
acquiring healthcare-associated infections (HAIs) [35], which represent a global threat. Moreover, the
increased mortality rate associated with infections sustained by drug-resistant bacteria is one of the main
concerns for humankind, and it therefore is important to characterize this aspect of the contaminating
microbial population, particularly in the hospital environment [36,37]. Despite the availability of
highly sensitive molecular methods, including metagenomics next-generation sequencing (NGS), the
study of the hospital microbiome has so far been mainly addressed by conventional culture-based
methods. However, such methodologies do not have high sensitivity, are time-consuming (depending
on the growth of microbial isolates on culture medium) and, mostly, their detection capacity is limited
to those microbes able to grow on selected culture media, thereby missing all the unsearched taxa.
Currently, the knowledge of microbial communities colonizing the hospital environment is quite
fragmented, as few studies have performed a comprehensive analysis of the hospital microbiota by
comparing different methodologies. Some studies have been performed by conventional culture-based
methods and others by molecular assays (qualitative PCR, real-time quantitative PCR, and later
NGS), but there are no data on the direct comparison of different types of analysis performed
in the same environment. In addition, despite some studies beginning to investigate different
types of built-environments, including healthcare structures for adult patients [38], and adult or
neonatal ICUs [39,40], there is no information about the level and type of microbial contamination in
pediatric hospitals.
Based on the potential relevance of the hospital microbiome for HAI transmission, which
can significantly affect patient recovery and outcomes, our study aimed to characterize the hospital
microbiome by comparing conventional and molecular analyses for their potential to detail precisely the
microbial communities contaminating different hospital wards and surfaces in a children’s healthcare
facility, focusing on the microorganisms of primary relevance for HAIs and on their AMR.
Eight different ward/room types were analyzed, including Pediatric Clinic (PC), Pediatric Surgery
(PS), Pediatric Oncology (PO), Neonatal Intensive and sub-Intensive Care Unit (NICU and NICUs),
children’s Intensive Care Unit (ICU), Surgical Rooms (SR) and Delivery Room (DR). Based on the
environment characteristics, sampled points included floor, bed footboard, operating bed, operating
table, incubator, and sink. Each location was simultaneously sampled following two different
methodologies according to subsequent microbiological (CFU count) or molecular analyses, the last
including qPCR microarray and NGS analyses of microbial genera/species, and qPCR microarray
analysis of the contaminating population resistome.
Overall, our results indicated important differences related to the different kinds of analysis
undertaken. In general, the results concerning the bacterial species searched for using conventional
or molecular qPCR microbiology showed a good level of concordance with NGS results, showing a
generally higher sensitivity of molecular compared to microbiological methods.
In particular, both CFU count and qPCR evidenced a different level of contamination in different
wards and surfaces, with PC being the most contaminated ward and floor/sink the most contaminated
surfaces. Staphylococcal contamination was the most prevalent in all analyzed areas, and the amount of
staphylococci was proportional to total contamination. However, other species of bacteria and mycetes
were also easily detectable, including Enterococcus spp., Enterobacteriaceae (K. pneumonia/Enterobacter,
E. coli, A. baumannii, P. mirabilis), P. aeruginosa, C, perfringens/difficile, C. albicans and A. fumigatus.
Consistently, with the sensitivity limits of the methods used, except for Staphylococcus spp. which were
detected at high efficiency with any of the methods, the other bacterial species appeared less detectable
when testing surfaces with culture-based conventional methods compared to qPCR and NGS, the
latter being the most sensitive methodology. NGS analysis, in fact, beside confirmation of the high
frequency of detection of Staphylococcus spp. (92.6% by NGS, 99.0% by qPCR and 81.5% by CFU count),
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further permitted identification of Pseudomonas spp. and Acinetobacter spp. at a very high efficiency
(in 75% and 65.7% of samples, respectively), compared to that obtained by culture-based (7.5%) or
qPCR assays (24.1%). This difference is particularly important when considering the potential of such
pathogens to be associated with difficult-to-treat HAIs, especially in ICU. Beside, NGS also evidenced
the presence, in almost all analyzed samples, of bacterial genera belonging to the skin/mucosa colonizer
group, such as Cutibacterium spp. (94.4%), Streptococcus spp. (detected in 82.4% of samples) and
Corynebacterium spp. (75.0% of samples). In addition, differently from the other techniques, NGS also
evidenced the environmental, non-anthropic component of the hospital bacterial contamination, as
it detected in most of samples environmental bacteria with low pathogenicity, including Paracoccus
spp. (70.4% of samples), and Rothia spp. (59.3% samples). Based on NGS results, Staphylococcus and
Cutibacterium genera represented the main contaminant of the floors, operating beds and tables. On
floors also Corynebacterium spp. and Streptococcus spp. were frequently identified, whereas in sinks
Streptococcus spp. and Staphylococcus spp. were the most prevalent genera, and Cutibacterium spp. and
Pseudomonas spp. (22/28) were also frequently detected. The incubators appeared mostly contaminated
by Cutibacterium spp. and Streptococcus spp. (both found in 100% of samples), but Pseudomonas spp.
and Staphylococcus spp. were also present (with mean relative abundance values ranging between 4%
to 8%). By contrast, in bed footboards Streptococcus spp. was the bacterium showing the highest mean
values of relative abundance (7%).
Being based on the characterization of the whole bacterial population, expressed as relative
abundance values, NGS generated results less superimposable with those obtained by CFU count,
whereas, in general, qPCR results showed a good level of concordance with CFU count, being based on
specific species detection and quantitation. The higher species-specificity of qPCR vs. NGS, however,
might have potentially led to an underestimation of the presence of some pathogens, as observed
for Acinetobacter, which was detected in 71/108 samples by NGS and 26/108 by qPCR. An overall
advantage of qPCR vs. NGS consisted in providing quantitative data, depicting more closely the level
of contamination in the different areas by searched pathogens. This is important when considering
for example the contamination by Staphylococcus spp. that, although detected by NGS in almost all
samples with high relative abundance values (including almost ‘sterile’ rooms such as SR and DR),
had a very different load in different areas and tested surfaces (SR/DR <<< PC, PO), providing a more
realistic description of the true level of contamination and of the related infectious risk.
Of note, the molecular assays were much more sensitive compared to conventional CFU count.
However, the higher amount of microbes detected by molecular versus microbiological methods, might
also be due to a different principle inherent in the two kinds of methodologies: CFU count only shows
living cells, capable of growing in selective media, whereas molecular methods show all the strains
present in the sample, being based on the extraction of total DNA from the bulk population. Thus, to
avoid overestimation of infectious contamination, in future works it would be interesting to introduce
differential extraction methods able to distinguish between alive and dead cells, for examples by using
propidium monoazide [41], since such approach would allow a deeper understanding of the types of
contamination actually able to transmit infections.
In general, NGS appears to be the only technique able to identify non-searched bacteria, and
this feature renders NGS a unique tool for monitoring contaminating bacterial species, being able to
identify even poorly represented species. Considering that current guidelines for hospital monitoring
include only a few species among those detected by NGS, this point might be kept in mind when
evaluating the safety of a hospital area. Interestingly, our NGS data were similar to those previously
reported by Lax et al. [38], but dissimilar from recent data obtained in Brazilian hospitals, showing a a
massive dominance of Acinetobacter and Pseudomonas in the hospital environment [42]. Overall, these
differences show the potential of NGS to define very precisely the different hospital microbiomes, as
proposed for confined habitats in general [43]. These data also strengthen the notion that NGS might be
a useful tool when it is important to understand the impact of confinement on microbial communities,
to address effectively the management of microbial contamination and associated infectious risk.
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However, even 16S rRNA gene sequencing shows limitations, which should be considered
when implementing it as a monitoring strategy. First, the analysis is performed on a short specific
sequence, and it limits the taxonomic resolution of closely related species [44]. In addition, it is not
able to distinguish between virulent or non-virulent strains, thus for accurate identification of certain
pathogenic species, multiplex PCR assays or Whole Genome Sequencing (WGS) should be added.
Also, 16S-based NGS cannot detect eukaryotic cells, such as mycetes, which can be very important
HAI-associated pathogens. Lastly, it does not provide quantitative data, but mean relative abundances.
One further aspect that should be considered when monitoring hospital contamination is
the drug-resistance of contaminating microorganisms, especially in light of the growing AMR of
HAI-associated pathogens. Toward this aim, the utilized qPCR microarray analysis was able to
characterize the resistome of the contaminating population, and provided results consistent with those
obtained by quantitative molecular assays. In fact, the most prevalent R genes were those that can be
detected in the species most prevalently found on surfaces, including the methicillin-resistance gene
(mecA), likely linked to the presence of Staphylococcus spp., followed by genes conferring resistance
against macrolides (ermA, ermB, ermC, msrA), β-lactams/carbapenems (VIM-group, OXA group), IMP-5
group and NDM gene, differentially distributed in the different wards. Such results can thus provide a
useful tool to monitor the spread of AMR in the hospital environment, and to assist design of efficient
interventions and strategical countermeasures, confirming previous observations [45].
Importantly, resistome results paralleled contamination analysis results, defining diverse areas in
the hospital environment, each characterized by different levels and types of contamination. Of note,
some intensive care units showed contamination and resistance levels not dissimilar from PC and PS
wards, highlighting the importance of contamination monitoring to prevent adverse events.
To our knowledge, our study is the first to compare directly conventional microbiology and
molecular analyses for the study of hospital microbiome. Overall, based on collected data, the
results of our investigation suggest that the high-throughput sequencing of 16S rRNA gene might
be an effective first-step tool for monitoring the whole composition of hospital bacterial microbiome,
eventually implementing amplicon sequence variants (ASV) analysis, which might improve the
results [46]. Such data, together with those derived from the analysis of mycome (by 18S analysis)
and of resistome/virulome, might provide a deeper knowledge of the hospital microbiome, possibly
leading to significant improvements in the development of new protocols to fight HAIs and AMR.
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